DLDaniel Joseph Laky

Daniel Joseph Laky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniel Joseph Laky has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimal experimental design using eigenvalue-based criteria with Pyomo.DoE

    by Daniel J. Laky, Shammah Lilonfe, Shawn B. Martin, Katherine A. Klise, Bethany L. Nicholson, John D. Siirola, Alexander W. Dowling

    Bridges optimization and data workflows by enabling automated eigenvalue-based experimental design for scalable, high-fidelity digital twin development.

  • Space biomanufacturing of lactic acid: Conceptual design and techno-economic analysis

    by Brenda Cansino-Loeza, Vernon Mclntosh, Krista Ternus, Mayur Bansal, Daniel J. Laky, Luke Roberson, Hal S. Alper, Victor M. Zavala

  • Open Access

    Market optimization and technoeconomic analysis of hydrogen-electricity coproduction systems

    by Daniel Joseph Laky, Nicole P. Cortes, John C. Eslick, Alexander A. Noring, Naresh Susarla, Chinedu Okoli, Miguel A. Zamarripa, Douglas A. Allan, John H. Brewer, Arun K. S. Iyengar, et al.

    We present an optimization framework to analyze emerging power systems technologies that coproduce power and alternative fuels. Emerging solid oxide-based systems have the potential to enable a reliable, efficient transition to cleaner energy.


  • Open Access

    A fast and scalable computational topology framework for the Euler characteristic

    by Daniel J. Laky, Victor M. Zavala

    The Euler characteristic (EC) is a powerful topological descriptor that can be used to quantify the shape of data objects that are represented as fields/manifolds. Fast methods for computing the EC are required to enable processing of high-throughput data and real-time implementations. This represents a challenge when processing high-resolution 2D field data (e.g., images) and 3D field data (e.g., video, hyperspectral images, and space-time data obtained from fluid dynamics and molecular simulations). In this work, we present parallel algorithms (and software implementations) to enable fast computations of the EC for 2D and 3D fields using vertex contributions. We test the proposed algorithms using synthetic data objects and data objects arising in real applications such as microscopy, 3D molecular dynamics simulations, and hyperspectral images. Results show that the proposed implementation can compute the EC a couple of orders of magnitude faster than GUDHI (an off-the-shelf and state-of-the art tool) and at speeds comparable to CHUNKYEuler (a tool tailored to scalable computation of the EC). The vertex contributions approach is flexible in that it can compute the EC as well as other topological descriptors such as perimeter, area, and volume (CHUNKYEuler can only compute the EC). Scalability with respect to memory use is also addressed by providing low-memory versions of the algorithms; this enables processing of data objects beyond the size of dynamic memory. All data and software needed for reproducing the results are shared as open-source code.


  • Open Access

    Using PharmaPy with Jupyter Notebook to teach digital design in pharmaceutical manufacturing

    by Daniel J. Laky, Daniel Casas‐Orozco, Mesfin Abdi, Xin Feng, Erin Wood, Gintaras V. Reklaitis, Zoltan K. Nagy

    The use of digital tools in pharmaceutical manufacturing has gained traction over the past two decades. Whether supporting regulatory filings or attempting to modernize manufacturing processes to adopt new and quickly evolving Industry 4.0 standards, engineers entering the workforce must exhibit proficiency in modeling, simulation, optimization, data processing, and other digital analysis techniques. In this work, a course that addresses digital tools in pharmaceutical manufacturing for chemical engineers was adjusted to utilize a new tool, PharmaPy, instead of traditional chemical engineering simulation tools. Jupyter Notebook was utilized as an instructional and interactive environment to teach students to use PharmaPy, a new, open‐source pharmaceutical manufacturing process simulator. Students were then surveyed to see if PharmaPy was able to meet the learning objectives of the course. During the semester, PharmaPy's model library was used to simulate both individual unit operations as well as multiunit pharmaceutical processes. Through the initial survey results, students indicated that: (i) through Jupyter Notebook, learning Python and PharmaPy was approachable from varied coding experience backgrounds and (ii) PharmaPy strengthened their understanding of pharmaceutical manufacturing through active pharmaceutical ingredient process design and development.


  • Simulation–Optimization Framework for the Digital Design of Pharmaceutical Processes Using Pyomo and PharmaPy

    by Daniel J. Laky, Daniel Casas-Orozco, Carl D. Laird, Gintaras V. Reklaitis, Zoltan K. Nagy

    The problem of performing model-based process design and optimization in the pharmaceutical industry is an important and challenging one both computationally and in choice of solution implementation. In this work, a framework is presented to directly utilize a process simulator via callbacks during derivative-based optimization. The framework allows users with little experience in translating mechanistic ODEs and PDEs to robust, fully discretized algebraic formulations, required for executing simultaneous equation-oriented optimization, to obtain mathematically guaranteed optima at a competitive solution time when compared with existing derivative-free and derivative-based frameworks. The effectiveness of the framework in accuracy of optimal solution as well as computational efficiency is analyzed on on two case studies: (i) an integrated 2-unit reaction synthesis train used for the synthesis of an anti-cancer active pharmaceutical ingredient, and (ii) a more complex flowsheet representing a common synthesis-purification-isolation train of a pharmaceutical manufacturing processes.


  • Evaluating Manual Sampling Locations for Regulatory and Emergency Response

    by Terranna Haxton, Katherine A. Klise, Daniel Laky, Regan Murray, Carl D. Laird, Jonathan B. Burkhardt

    Drinking water systems commonly use manual or grab sampling to monitor water quality, identify or confirm issues, and verify that corrective or emergency response actions have been effective. In this paper, the effectiveness of regulatory sampling locations for emergency response is explored. An optimization formulation based on the literature was used to identify manual sampling locations to maximize overall nodal coverage of the system. Results showed that sampling locations could be effective in confirming incidents for which they were not designed. When evaluating sampling locations optimized for emergency response against regulatory scenarios, the average performance was reduced by 3%–4%, while using optimized regulatory sampling locations for emergency response reduced performance by 7%–10%. Secondary constraints were also included in the formulation to ensure geographical and water age diversity with minimal impact on the performance. This work highlighted that regulatory sampling locations provide value in responding to an emergency for these networks.


  • PharmaPy: An object-oriented tool for the development of hybrid pharmaceutical flowsheets

    by Daniel Casas-Orozco, Daniel Laky, Vivian Wang, Mesfin Abdi, X. Feng, E. Wood, Carl Laird, Gintaras V. Reklaitis, Zoltan K. Nagy


  • Open Access

    An Optimization-Based Framework to Define the Probabilistic Design Space of Pharmaceutical Processes with Model Uncertainty

    by Daniel Laky, Shu Xu, Jose S. Rodriguez, Shankar Vaidyaraman, Salvador García Muñoz, Carl Laird

    To increase manufacturing flexibility and system understanding in pharmaceutical development, the FDA launched the quality by design (QbD) initiative. Within QbD, the design space is the multidimensional region (of the input variables and process parameters) where product quality is assured. Given the high cost of extensive experimentation, there is a need for computational methods to estimate the probabilistic design space that considers interactions between critical process parameters and critical quality attributes, as well as model uncertainty. In this paper we propose two algorithms that extend the flexibility test and flexibility index formulations to replace simulation-based analysis and identify the probabilistic design space more efficiently. The effectiveness and computational efficiency of these approaches is shown on a small example and an industrial case study.